已發(fā)表的部分文獻: 標(biāo)題:Bosentan reverses the pro-fibrotic phenotype of systemic sclerosis dermal fibroblasts via increasing DNA binding ability of transcription factor Fli1.作者:Akamata K, Asano Y, Aozasa N, Noda S, Taniguchi T, Takahashi T, Ichimura Y, Toyama T, Sato S;雜志名稱:Arthritis Res Ther 標(biāo)題:Apoptotic response through a high mobility box 1 protein-dependent mechanism in LPS/GalN-induced mouse liver failure and glycyrrhizin-mediated inhibition.作者:Kuroda N, Inoue K, Ikeda T, Hara Y, Wake K, Sato T;雜志名稱:PLoS One 標(biāo)題:Cladosporol A, a new peroxisome proliferator-activated receptor γ (PPARγ) ligand, inhibits colorectal cancer cells proliferation through β-catenin/TCF pathway inactivation.作者:Zurlo D, Assante G, Moricca S, Colantuoni V, Lupo A;雜志名稱:Biochim Biophys Acta 標(biāo)題:Hydrogen sulfide suppresses oxidized low-density lipoprotein (ox-LDL)-stimulated monocyte chemoattractant protein 1 generation from macrophages via the nuclear factor κB (NF-κB) pathway.作者:Du J, Huang Y, Yan H, Zhang Q, Zhao M, Zhu M, Liu J, Chen SX, Bu D, Tang C, Jin H;雜志名稱:J Biol Chem 標(biāo)題:Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response.作者:Venteclef N, Delerive P;雜志名稱:J Biol Chem 標(biāo)題:Cloning and characterization of the rat lysyl oxidase gene promoter: identification of core promoter elements and functional nuclear factor I-binding sites.作者:Gao S, Zhao Y, Kong L, Toselli P, Chou IN, Stone P, Li W;雜志名稱:J Biol Chem 標(biāo)題:AS1411 alters the localization of a complex containing protein arginine methyltransferase 5 and nucleolin.作者:Teng Y, Girvan AC, Casson LK, Pierce WM Jr, Qian M, Thomas SD, Bates PJ;雜志名稱:Cancer Res 標(biāo)題:Functional roles of Fli-1, a member of the Ets family of transcription factors, in human breast malignancy.作者:Sakurai T, Kondoh N, Arai M, Hamada J, Yamada T, Kihara-Negishi F, Izawa T, Ohno H, Yamamoto M, Oikawa T;雜志名稱:Cancer Sci Epigentek 公司是全球領(lǐng)先的表觀遺傳學(xué)相關(guān)研究的技術(shù)創(chuàng)新者和產(chǎn)品開發(fā)供應(yīng)商。開發(fā)了超過700多個專利產(chǎn)品,為表觀遺傳學(xué)方面的研究和新藥研發(fā)提供全面系統(tǒng)的解決方案,涵蓋樣品制備、DNA/RNA甲基化(5-mc, 5-hmc, 5-fc, m6A)/DNMT分析、ChIP、組蛋白甲基化/乙酰化/去乙酰化/磷酸化/SUMO-等領(lǐng)域,提供小分子抑制劑、蛋白質(zhì)、抗體、以及分析試劑盒產(chǎn)品。